Zhitong Finance App News, Bairen Medical (688198.SH) issued an announcement. Recently, after review by the State Drug Administration, the company's self-developed innovative product Complex Congenital Heart Disease Valve Supplement (China Machinery Note 20263131971) was approved for registration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.